Organization · Venture Capital
Regent Partners
Regent Partners is a Seoul-based alternative investment firm specializing in venture capital and private equity, focusing on early and growth-stage investments in healthcare and ICT. The firm also engages in middle-market M&A and buyout transactions.
Overview
What Regent Partners does
What Regent Partners is
Regent Partners is a Seoul-based alternative investment firm specializing in venture capital and private equity, focusing on early and growth-stage investments in healthcare and ICT. The firm also engages in middle-market M&A and buyout transactions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Regent Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Regent Partners as a funder
Investment thesis
Regent Partners combines growth-stage venture discipline with active value creation, focusing on companies with strong growth potential, particularly in healthcare and ICT.
Focus narrative
Regent Partners invests in early and growth-stage companies, emphasizing healthcare and ICT sectors. The firm has expanded its investment strategy to include middle-market mergers and acquisitions (M&A) and buyout transactions, partnering with companies that demonstrate strong growth potential.
Value beyond capital
Regent Partners adds value to its portfolio companies by leveraging global networks and investment experience, assisting with initial overseas expansion, management resources, global management capabilities, joint-venture partnership opportunities, follow-on funding, and scale-up M&A.
Terms and economics
- Typical check
- $270,000–$6,250,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Growth Equity
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Regent Partners has a diverse portfolio that includes notable companies such as LOVEBUG, specializing in probiotics; LASE INNOVATION, focusing on innovative healthcare solutions; and PAYWATCH, providing payment solutions. Other portfolio companies include INNBEAUTY, WYATT, and TMD LAB, among others across e-commerce, bio/health, and ICT sectors.
Common questions
What to know about Regent Partners
Upseed classifies Regent Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.